175 related articles for article (PubMed ID: 9445079)
1. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants.
Carrillo C; Wigdorovitz A; Oliveros JC; Zamorano PI; Sadir AM; Gómez N; Salinas J; Escribano JM; Borca MV
J Virol; 1998 Feb; 72(2):1688-90. PubMed ID: 9445079
[TBL] [Abstract][Full Text] [Related]
2. Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants.
Carrillo C; Wigdorovitz A; Trono K; Dus Santos MJ; Castañón S; Sadir AM; Ordas R; Escribano JM; Borca MV
Viral Immunol; 2001; 14(1):49-57. PubMed ID: 11270596
[TBL] [Abstract][Full Text] [Related]
3. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1.
Wigdorovitz A; Carrillo C; Dus Santos MJ; Trono K; Peralta A; Gómez MC; Ríos RD; Franzone PM; Sadir AM; Escribano JM; Borca MV
Virology; 1999 Mar; 255(2):347-53. PubMed ID: 10069960
[TBL] [Abstract][Full Text] [Related]
4. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1.
Wigdorovitz A; Pérez Filgueira DM; Robertson N; Carrillo C; Sadir AM; Morris TJ; Borca MV
Virology; 1999 Nov; 264(1):85-91. PubMed ID: 10544132
[TBL] [Abstract][Full Text] [Related]
5. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants.
Dus Santos MJ; Wigdorovitz A; Trono K; Ríos RD; Franzone PM; Gil F; Moreno J; Carrillo C; Escribano JM; Borca MV
Vaccine; 2002 Jan; 20(7-8):1141-7. PubMed ID: 11803075
[TBL] [Abstract][Full Text] [Related]
6. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
[TBL] [Abstract][Full Text] [Related]
7. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection.
Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y
Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
[TBL] [Abstract][Full Text] [Related]
9. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
[TBL] [Abstract][Full Text] [Related]
10. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
11. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase.
Cedillo-Barrón L; Foster-Cuevas M; Belsham GJ; Lefèvre F; Parkhouse RME
J Gen Virol; 2001 Jul; 82(Pt 7):1713-1724. PubMed ID: 11413383
[TBL] [Abstract][Full Text] [Related]
12. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
13. Antibodies elicited by a biosynthetic peptide related to a major immunogenic area of FMDV A12.
Borca MV; Moore DM; Srikumaran S; Morgan DO
Viral Immunol; 1990; 3(2):147-60. PubMed ID: 1694429
[TBL] [Abstract][Full Text] [Related]
14. [Protective immune response of guinea pigs against challenge with foot and mouth disease virus by immunization with foliar extracts from transgenic tomato plants expressing the FMDV structural protein VP1].
Pan L; Zhang YG; Wang YL; Wang BQ; Xie QG
Wei Sheng Wu Xue Bao; 2006 Oct; 46(5):796-801. PubMed ID: 17172031
[TBL] [Abstract][Full Text] [Related]
15. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization.
Shieh JJ; Liang CM; Chen CY; Lee F; Jong MH; Lai SS; Liang SM
Vaccine; 2001 Jul; 19(28-29):4002-10. PubMed ID: 11427276
[TBL] [Abstract][Full Text] [Related]
17. Protective immune response to 16 kDa immunoreactive recombinant protein encoding the C-terminal VP1 portion of Foot and Mouth Disease Virus type Asia 1.
Bayry J; Prabhudas K; Gopalakrishna S; Patil PK; Ramakrishna C; Misra LD; Suryanarayana VV
Microbiol Immunol; 1999; 43(8):765-71. PubMed ID: 10524794
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
Zhou G; Wang H; Wang F; Yu L
Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
[TBL] [Abstract][Full Text] [Related]
19. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72.
Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD
Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734
[TBL] [Abstract][Full Text] [Related]
20. Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.
Doel TR; Gale C; Brooke G; DiMarchi R
J Gen Virol; 1988 Sep; 69 ( Pt 9)():2403-6. PubMed ID: 2457649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
